SG11202103567RA - Methods of treatment of inflammatory conditions and associated infections - Google Patents
Methods of treatment of inflammatory conditions and associated infectionsInfo
- Publication number
- SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- methods
- inflammatory conditions
- associated infections
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018903823A AU2018903823A0 (en) | 2018-10-10 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
AU2018903822A AU2018903822A0 (en) | 2018-10-10 | Compositions and methods of treatment of inflammatory conditions and infections | |
AU2019901176A AU2019901176A0 (en) | 2019-04-05 | Compositions and methods of treatment of inflammatory conditions and associated infections | |
AU2019901175A AU2019901175A0 (en) | 2019-04-05 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
PCT/AU2019/051092 WO2020073088A1 (en) | 2018-10-10 | 2019-10-10 | Methods of treatment of inflammatory conditions and associated infections |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202103567RA true SG11202103567RA (en) | 2021-05-28 |
Family
ID=70163621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103567RA SG11202103567RA (en) | 2018-10-10 | 2019-10-10 | Methods of treatment of inflammatory conditions and associated infections |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210338749A1 (en) |
EP (1) | EP3863656A4 (en) |
JP (1) | JP2022504792A (en) |
CN (1) | CN114206362A (en) |
AU (1) | AU2019356524A1 (en) |
CA (1) | CA3124725A1 (en) |
SG (1) | SG11202103567RA (en) |
WO (1) | WO2020073088A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4255456A1 (en) * | 2020-12-01 | 2023-10-11 | Servatus Ltd | Methods for improving sleep quality |
KR20230165747A (en) * | 2020-12-09 | 2023-12-05 | 세르바투스 리미티드 | Combination therapy for inflammatory joint disorders |
CA3222876A1 (en) * | 2021-08-19 | 2023-02-23 | Katja Johnson | Postbiotic |
AU2022331116A1 (en) * | 2021-08-19 | 2024-01-18 | Société des Produits Nestlé S.A. | Postbiotic |
US20230141346A1 (en) * | 2021-11-05 | 2023-05-11 | Trillium Medical Products, LLC | Infused undergarment |
WO2023097375A1 (en) * | 2021-12-02 | 2023-06-08 | Servatus Ltd | Methods for the treatment of constipation |
CN115725469A (en) * | 2022-11-28 | 2023-03-03 | 广西大学 | Lactobacillus paracasei and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1306716B1 (en) * | 1999-06-21 | 2001-10-02 | Mendes S U R L | ASSOCIATION OF LACTIC BACTERIA AND ITS USE FOR THE PREVENTION AND / OR THERAPEUTIC TREATMENT OF INFECTIONS AND INFLAMMATORY STATES. |
US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
ITMI20032391A1 (en) * | 2003-12-05 | 2005-06-06 | Consiglio Nazionale Ricerche | MENSA OLIVES CONTAINING PROBIOTIC MICRO-ORGANISMS. |
CN102014888A (en) * | 2007-07-03 | 2011-04-13 | 达努塔·克鲁谢夫斯卡 | New medical applications of alpha-ketoglutarate |
JP4876262B2 (en) * | 2008-10-24 | 2012-02-15 | 防衛省技術研究本部長 | Novel plant lactic acid strain having anti-inflammatory effect, preventive and therapeutic agent, inhibitor and additive for inflammatory bowel disease or chronic diarrhea using the strain |
AU2010339573B2 (en) * | 2009-12-31 | 2014-08-28 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
US9492487B2 (en) * | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
CA2833937C (en) * | 2011-05-16 | 2022-04-05 | Organobalance Medical Ag | Lactobacillus strains, compositions containing them and use of the strains to prevent or treat conditions caused by streptococcus pyogenes |
ES2959503T3 (en) * | 2013-04-23 | 2024-02-26 | Terragen Holdings Ltd | Bacterial strain that presents antimicrobial activity used in plants |
ITMI20130793A1 (en) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES. |
KR20150023132A (en) * | 2013-08-23 | 2015-03-05 | (주) 아이투비 | Composit for improving atopic dermatitis |
CN104000184A (en) * | 2013-12-09 | 2014-08-27 | 胡安然 | Food for alleviating atrophic gastritis |
WO2016179639A1 (en) * | 2015-05-13 | 2016-11-17 | Markson Ro | Probiotic compositions and uses thereof |
CN106860441B (en) * | 2017-02-10 | 2019-12-31 | 中国医学科学院医药生物技术研究所 | Application of 4-oxo-2-butenamide derivative in preparation of bacteriostatic agent |
KR101917497B1 (en) * | 2017-02-18 | 2018-11-09 | 박병희 | Novel Lactobacillus buchneri and Use thereof |
TWI607758B (en) * | 2017-03-07 | 2017-12-11 | 景岳生物科技股份有限公司 | Lactobacillus paracasei strain gmnl-653 and composition having the same for improving psoriasis symptoms |
WO2018187838A1 (en) * | 2017-04-11 | 2018-10-18 | Servatus Ltd | Methods for the treatment of inflammation and inflammatory conditions |
US11406672B2 (en) * | 2018-03-14 | 2022-08-09 | Sustainable Community Development, Llc | Probiotic composition and feed additive |
-
2019
- 2019-10-10 JP JP2021520168A patent/JP2022504792A/en active Pending
- 2019-10-10 CA CA3124725A patent/CA3124725A1/en active Pending
- 2019-10-10 SG SG11202103567RA patent/SG11202103567RA/en unknown
- 2019-10-10 EP EP19870476.9A patent/EP3863656A4/en active Pending
- 2019-10-10 CN CN201980082026.6A patent/CN114206362A/en active Pending
- 2019-10-10 US US17/284,207 patent/US20210338749A1/en active Pending
- 2019-10-10 WO PCT/AU2019/051092 patent/WO2020073088A1/en unknown
- 2019-10-10 AU AU2019356524A patent/AU2019356524A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN114206362A (en) | 2022-03-18 |
AU2019356524A1 (en) | 2021-05-13 |
EP3863656A4 (en) | 2022-06-29 |
EP3863656A1 (en) | 2021-08-18 |
WO2020073088A1 (en) | 2020-04-16 |
US20210338749A1 (en) | 2021-11-04 |
JP2022504792A (en) | 2022-01-13 |
CA3124725A1 (en) | 2020-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202103567RA (en) | Methods of treatment of inflammatory conditions and associated infections | |
IL273693A (en) | Treatment of inflammatory disorders | |
EP3609515A4 (en) | Methods for the treatment of inflammation and inflammatory conditions | |
IL281277A (en) | Compositions and methods for the treatment of viral infections | |
ZA201801266B (en) | Composition and method for treatment and prophylaxis of intestinal infection and inflammation | |
GB201804514D0 (en) | Treatment of pyroptosis | |
EP3503903A4 (en) | Ascaroside treatment of autoimmune and inflammatory diseases | |
IL272321A (en) | Methods and compositions for treatment of amyloid deposition diseases | |
IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
IL283782A (en) | Anellosomes and methods of use | |
GB201804515D0 (en) | Treatment of necroptosis | |
SG11201809811VA (en) | Compositions and methods for treatment of inflammation or infection of the eye | |
IL281775A (en) | Methods of treatment of infections using bacteria | |
ZA202006569B (en) | Methods of treating fungal infections | |
IL276053A (en) | Therapeutic-gard and method of use thereof | |
PT3708174T (en) | Methods and treatment of trauma | |
SG10201913129QA (en) | Treatment and diagnosis of inflammatory disorders | |
SG11202003009QA (en) | Methods of treating bacterial infections | |
GB201810923D0 (en) | Compositions and method of treatment | |
EP3606516A4 (en) | Method of treating and preventing infections | |
AU2018903822A0 (en) | Compositions and methods of treatment of inflammatory conditions and infections | |
GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
EP4003283C0 (en) | Treatment of inflammatory skin conditions | |
AU2019901176A0 (en) | Compositions and methods of treatment of inflammatory conditions and associated infections | |
SI3781172T1 (en) | Treatment of pneumonia |